Fellows are encouraged to pursue scholarly activity aligned with their interests and career goals. Opportunities include:
- Participation in investigator-initiated and industry-sponsored clinical trials
- Neuroimaging and biomarker studies
- Abstract and manuscript development with faculty mentorship
Protected research time and support for national presentations are integral components of the fellowship.
Following is our list of current study at our center.
|
STUDY TITLE
|
STUDY ACRONYM
|
PI NAME
|
STUDY TYPE
|
IRB NUMBER
|
FUNDING TYPE
|
|
A Randomized controlled, open-label, rater-blinded pragmatic trial, "Treatment of Inflammatory Myelitis and Optic Neuritis with Early Versus Rescue Plasma Exchange (Timely-Plex)
|
TIMELY-PLEX
|
Dr. Anadani
|
Interventional / Clinical Trial -Pragmatic clinical trial
|
Ongoing IRB submission
|
PCORI funded through JHU
|
|
Real World Experience with BRIUMVI® (UblituximAB-Xiiy) Treated Patients: A Longitudinal Registry Study (ENABLE)
|
ENABLE
|
Dr. Anadani
|
Interventional / Clinical Trial - Phase IV study
|
19184
|
Pharma funded
|
|
Is Substance Use Disorder a Risk Factor for Multiple Sclerosis?
|
Substance Use Disorder and MS - Survey
|
Dr. Anadani
|
Survey-Based
|
14623
|
|
|
MOGAD - Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
|
MOGAD
|
Dr. Anadani
|
Retrospective
|
4184
|
|